RTOG 9003 Study Indicates That Hyperfractionated Radiation Therapy Improves Local-Regional Control Without Increasing Late Toxicity for Patients with Locally Advanced Head and Neck Cancer
American Society for Radiation Oncology (ASTRO)Patients with locally advanced squamous cell carcinoma of the head and neck treated with hyperfractionated radiation therapy (HFX) experienced improved local-regional control and, with patients censored at five years, improved overall survival with no increase in late toxicity, according to a study published in the May 1, 2014 edition of the International Journal of Radiation Oncology ● Biology ● Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).